+

WO2002062841A3 - Proteines secretees - Google Patents

Proteines secretees Download PDF

Info

Publication number
WO2002062841A3
WO2002062841A3 PCT/US2002/002616 US0202616W WO02062841A3 WO 2002062841 A3 WO2002062841 A3 WO 2002062841A3 US 0202616 W US0202616 W US 0202616W WO 02062841 A3 WO02062841 A3 WO 02062841A3
Authority
WO
WIPO (PCT)
Prior art keywords
secp
secreted proteins
provides
polynucleotides
agonists
Prior art date
Application number
PCT/US2002/002616
Other languages
English (en)
Other versions
WO2002062841A2 (fr
Inventor
Tom Y Tang
Henry Yue
Ameena R Gandhi
Monique G Yao
Bridget A Warren
Li Ding
Brendan M Duggan
Yuming Xu
Junming Yang
Kavitha Thangavelu
Preeti G Lal
Cynthia D Honchell
Narinder K Chawla
Sally Lee
Ernestine A Lee
Thomas W Richardson
Mariah R Baughn
Vicki S Elliott
Original Assignee
Incyte Genomics Inc
Tom Y Tang
Henry Yue
Ameena R Gandhi
Monique G Yao
Bridget A Warren
Li Ding
Brendan M Duggan
Yuming Xu
Junming Yang
Kavitha Thangavelu
Preeti G Lal
Cynthia D Honchell
Narinder K Chawla
Sally Lee
Ernestine A Lee
Thomas W Richardson
Mariah R Baughn
Vicki S Elliott
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc, Tom Y Tang, Henry Yue, Ameena R Gandhi, Monique G Yao, Bridget A Warren, Li Ding, Brendan M Duggan, Yuming Xu, Junming Yang, Kavitha Thangavelu, Preeti G Lal, Cynthia D Honchell, Narinder K Chawla, Sally Lee, Ernestine A Lee, Thomas W Richardson, Mariah R Baughn, Vicki S Elliott filed Critical Incyte Genomics Inc
Priority to EP02714797A priority Critical patent/EP1355935A2/fr
Priority to JP2002563193A priority patent/JP2004537273A/ja
Priority to US10/470,360 priority patent/US20040063924A1/en
Priority to CA002434944A priority patent/CA2434944A1/fr
Publication of WO2002062841A2 publication Critical patent/WO2002062841A2/fr
Publication of WO2002062841A3 publication Critical patent/WO2002062841A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Cette invention concerne des protéines sécrétées humaines (SECP) et des polynucléotides qui identifient ces protéines et codent pour ces dernières. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. Sont également décrites des méthodes de diagnostic, de traitement ou de prévention de troubles en rapport avec l'expression aberrante desdites SECP.
PCT/US2002/002616 2001-02-02 2002-01-28 Proteines secretees WO2002062841A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP02714797A EP1355935A2 (fr) 2001-02-02 2002-01-28 Proteines secretees
JP2002563193A JP2004537273A (ja) 2001-02-02 2002-01-28 分泌タンパク質
US10/470,360 US20040063924A1 (en) 2002-01-28 2002-01-28 Secreted proteins
CA002434944A CA2434944A1 (fr) 2001-02-02 2002-01-28 Proteines secretees

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US26619501P 2001-02-02 2001-02-02
US60/266,195 2001-02-02
US26792401P 2001-02-08 2001-02-08
US60/267,924 2001-02-08
US26811201P 2001-02-09 2001-02-09
US26781601P 2001-02-09 2001-02-09
US60/268,112 2001-02-09
US60/267,816 2001-02-09
US27163901P 2001-02-26 2001-02-26
US60/271,639 2001-02-26
US31781801P 2001-09-07 2001-09-07
US60/317,818 2001-09-07
US34355301P 2001-12-21 2001-12-21
US60/343,553 2001-12-21

Publications (2)

Publication Number Publication Date
WO2002062841A2 WO2002062841A2 (fr) 2002-08-15
WO2002062841A3 true WO2002062841A3 (fr) 2003-06-05

Family

ID=27569522

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/002616 WO2002062841A2 (fr) 2001-02-02 2002-01-28 Proteines secretees

Country Status (4)

Country Link
EP (1) EP1355935A2 (fr)
JP (1) JP2004537273A (fr)
CA (1) CA2434944A1 (fr)
WO (1) WO2002062841A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0201808D0 (en) * 2002-01-25 2002-03-13 European Molecular Biology Lab Embl Protein
DE10213762A1 (de) * 2002-03-26 2003-10-09 Boehringer Ingelheim Int Neues costimulierendes Molekül und dessen Verwendung
US20070059294A1 (en) * 2003-08-13 2007-03-15 Toshihiro Nakajima Therapeutiv preparation for hematopoietic disease

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007198A2 (fr) * 1995-08-11 1997-02-27 Genetics Institute, Inc. Sequences d'adn et proteines secretees codees par celles-ci

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007198A2 (fr) * 1995-08-11 1997-02-27 Genetics Institute, Inc. Sequences d'adn et proteines secretees codees par celles-ci

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] EBI; 22 December 1997 (1997-12-22), HILLIER L. ET AL.: "zj36b08.s1 Soares fetal liver spleen 1NFLS S1 Homo sapiens cDNA clone", XP002224509, Database accession no. AA700861 *
DATABASE EMBL [online] EBI; 8 May 1998 (1998-05-08), STRAUSBERG R.: "on72g01.s1 Soares NFL T GBC S1 Homo sapiens cDNA clone", XP002224510, Database accession no. AA954284 *
DATABASE SWISS-PROT [online] EBI; 1 May 2000 (2000-05-01), ADAMS M.D. ET AL.: "CG13076 protein", XP002224511, Database accession no. Q9VUX3 *
DATABASE SWISS-PROT [online] EBI; 1 May 2000 (2000-05-01), LIN X. ET AL.: "Putative pectinacetylesterase", XP002224512, Database accession no. Q9SR22 *
JACOBS K A ET AL: "A genetic selection for isolating cDNAs encoding secreted proteins", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, ELSEVIER SCIENCE PUBLISHERS, BARKING, GB, vol. 198, no. 1-2, 1 October 1997 (1997-10-01), pages 289 - 296, XP004116069, ISSN: 0378-1119 *
KLEIN R D ET AL: "SELECTION FOR GENES ENCODING SECRETED PROTEINS AND RECEPTORS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, no. 14, 9 July 1996 (1996-07-09), pages 7108 - 7113, XP002061411, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
EP1355935A2 (fr) 2003-10-29
JP2004537273A (ja) 2004-12-16
WO2002062841A2 (fr) 2002-08-15
CA2434944A1 (fr) 2002-08-15

Similar Documents

Publication Publication Date Title
WO2000015793A3 (fr) Proteines gpcr humaines
WO2002038602A3 (fr) Proteines secretees
WO2001098353A3 (fr) Proteines secretees
WO2002048337A3 (fr) Proteines secretees
WO2003029437A3 (fr) Proteines secretees
WO2001079291A3 (fr) Proteines secretees
WO2002072794A3 (fr) Proteines de la superfamille des immunoglobulines
WO2003004615A3 (fr) Proteines secretees
WO2002070669A3 (fr) Proteines secretees
WO2002086069A3 (fr) Proteines secretees
WO2002097060A3 (fr) Proteines associees aux carbohydrates
WO2003068943A3 (fr) Proteines secretees
WO2002094990A3 (fr) Recepteurs et proteines associees aux membranes
WO2001085942A3 (fr) Proteines associees au cytosquelette
WO2002026982A3 (fr) Proteines secretees
WO2003087300A3 (fr) Proteines secretees
WO2002053719A3 (fr) Proteines associees au cytosquelette
WO2002066646A3 (fr) Proteines associees a la neurotransmission
WO2002079441A3 (fr) Proteines secretees
WO2001051636A3 (fr) Proteines secretees
WO2003016506A3 (fr) Proteines secretees
WO2002057454A3 (fr) Proteines associees a une membrane et a des recepteurs
WO2002062841A3 (fr) Proteines secretees
WO2004094589A3 (fr) Proteines secretees
WO2002042330A3 (fr) Proteines associees a un cystosquelette

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2434944

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002714797

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10470360

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2002563193

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2002714797

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2002714797

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载